Maria Chiara Rossi

12PUBLICATIONS
19CO-AUTHORS
Medical biochemistry - carbohydratesPacific Peoples medicine and treatmentsDisease surveillanceMedical biotechnology diagnostics (incl. biosensors)Adolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 01, 2025
Comparative Effectiveness of Switching From First-Generation Basal Insulins to Either Glargine 300 U/mL or Degludec 100 U/mL in Children and Adolescents With Type 1 Diabetes: Results From the ISPED CARD Clinical Registry.

Ivana Rabbone, Riccardo Bonfanti, Giusi Graziano

|Feb 07, 2025
Treating VVA improves symptom severity and patient-reported outcomes: 6-month PEONY results.

Rossella E Nappi, Maria Cristina Meriggiola, Francesca Albani

|Oct 17, 2024
When Does Metabolic Memory Start? Insights From the Association of Medical Diabetologists Annals Initiative on Stringent HbA1c Targets.

Giuseppina T Russo, Antonio Nicolucci, Giuseppe Lucisano

|Jun 10, 2024
Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world study.

Raffaele Napoli, Antonio Nicolucci, Monica Larosa

|May 24, 2024
Effectiveness of switching from first-generation basal insulin to Glargine 300 U/mL in children and adolescents with type 1 diabetes: results from the ISPED CARD database.

Maria Chiara Rossi, Riccardo Bonfanti, Giusi Graziano

|Nov 11, 2019
Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety.

Paola Ponzani, Cesare Berra, Alessandra Di Lelio

Pageof 2

Frequent Collaborators

4 joint publications

Antonio Nicolucci

2 joint publications

Antonio Ceriello

1 joint publications

Carlo Giorda

1 joint publications

Raffaele Napoli